ESMO Congress 2025

UBC is excited to join clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world to shape the future of cancer care at ESMO 2025.

Meet with our Safety & Risk Management and Evidence Development Teams

Our evidence development solutions provide expert-driven real-world evidence tailored to specialty patient populations to uncover more valuable insights, maximize commercial positioning, and optimize regulatory approval for the long-term value of your therapy. Leveraging real-world data and the latest biopharma technology platforms and software, we create solutions that are innovative as well as grounded in real-world patient experience, from modernized study design and execution to late-stage research.

Meanwhile, our safety and risk management team creates authoritative, trusted, and reliable strategies to inform and educate providers, patients, and regulators about the benefit/risk profile of specialty therapies. With PV services curated over decades of leadership, we ensure comprehensive, tailored drug safety and global risk management solutions that are sophisticated, tech-enabled, and regulatory compliant.

At UBC, we connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation. Meet our team to learn how our consultative approach and deep experience can benefit your product across its lifecycle.